PBE
Invesco Biotechnology & Genome ETF
1W: -2.2%
1M: -3.7%
3M: +3.4%
YTD: +15.4%
1Y: +32.7%
3Y: +64.8%
5Y: +23.5%
$95.07
-0.03 (-0.03%)
Weekly Expected Move ±2.9%
$90
$92
$95
$98
$101
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
56.5
★★★★★
Altman Z-Score
10.27
Safe
Weight Coverage
100%
of portfolio analyzed
Holdings Matched
30
with fundamental data
InsiderStreet Scorecard
★★★★★
56.5
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
10.27
Safe Zone (>2.99)
Piotroski F-Score
5.6 / 9
Moderate
Beneish M-Score
-0.44
Possible Manipulator
Credit Score
—
Earnings Quality
55.0 / 100
Portfolio Valuation
P/E
39.52x
P/B
7.04x
P/S
6.72x
EV/EBITDA
26.51x
EV/Revenue
7.29x
P/FCF
21.69x
P/OCF
19.44x
PEG
2.42x
Earnings Yield
2.53%
FCF Yield
4.61%
OCF Yield
5.14%
Median P/E
17.76x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+14.7%
Net Income
+18.6%
EPS
+20.0%
FCF
+36.4%
EBITDA
+9.8%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+24.2%
Rev CAGR 5Y
+23.4%
EPS CAGR 3Y
+16.3%
EPS CAGR 5Y
+5.8%
FCF CAGR 3Y
+30.7%
FCF CAGR 5Y
+15.9%
EBITDA CAGR 3Y
+8.1%
EBITDA CAGR 5Y
+9.3%
Payout Ratio
8.67%
Buyback Yield
1.38%
Dividend Yield
0.50%
Total Shareholder Return
1.24%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$95.07
Median 1Y
$100.42
5th Pctile
$67.30
95th Pctile
$150.13
Ann. Volatility
25.0%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 39.52 |
| Portfolio P/B | 7.04 |
| Portfolio P/S | 6.72 |
| EV/EBITDA | 26.51 |
| EV/Revenue | 7.29 |
| P/FCF | 21.69 |
| P/OCF | 19.44 |
| PEG | 2.42 |
| Earnings Yield | 2.53% |
| FCF Yield | 4.61% |
| OCF Yield | 5.14% |
| Median P/E | 17.76 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 75.89% |
| Operating Margin | 17.93% |
| Net Margin | 12.45% |
| FCF Margin | 30.18% |
| ROE | 13.25% |
| ROA | 5.53% |
| ROIC | 11.01% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.89 |
| Debt/Assets | 0.37 |
| Net Debt/EBITDA | 1.74 |
| Interest Coverage | 5.47 |
| Current Ratio | 1.91 |
| Quick Ratio | 1.60 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 14.66% |
| Net Income Growth | 18.59% |
| EPS Growth | 20.04% |
| FCF Growth | 36.45% |
| EBITDA Growth | 9.85% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 24.17% |
| Revenue CAGR 5Y | 23.39% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 16.33% |
| EPS CAGR 5Y | 5.75% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 30.72% |
| FCF CAGR 5Y | 15.92% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 8.14% |
| EBITDA CAGR 5Y | 9.26% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 14.11% |
| Net Income CAGR 5Y | 4.72% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 56.5 |
| IS Profitability | 56.2 |
| IS Balance Sheet | 61.0 |
| IS Earnings Quality | 55.0 |
| IS Growth | 53.7 |
| IS Value | 42.3 |
| IS Momentum | 67.9 |
| IS Safety | 76.3 |
| IS Quality | 64.6 |
| Altman Z-Score | 10.27 |
| Piotroski F-Score | 5.64 |
| Beneish M-Score | -0.44 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.50% |
| Payout Ratio | 8.67% |
| Buyback Yield | 1.38% |
| Total Shareholder Return | 1.24% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.767 |
| Earnings Stability | 0.388 |
| Earnings Persistence | 0.638 |
| Margin Stability | 0.848 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | 17.76 |
| Median P/B | 3.82 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 99.92% |
| Holdings Matched | 30 |
| Total Holdings | 31 |